Publications:

Mefatinib as first-line treatment of patients with advanced EGFR-mutant non-small-cell lung cancer: a phase Ib/II efficacy and biomarker study.

Signal Transduction And Targeted Therapy

Wang, Pingli P; Li, Yuping Y; Lv, Dongqing D; Yang, Lingge L; Ding, Liren L; Zhou, Jianya J; Hong, Wei W; Chen, Youfei Y; Zhang, Dongqing D; He, Susu S; Zhou, Jianying J; Wang, Kai K

Publication Date: 2021-11-01

Variant appearance in text: POLE: 6330+5G>C

PubMed Link: 34719670

Variant Present in the following documents:

• 41392_2021_773_MOESM2_ESM.xlsx, sheet 2

View BVdb publication page